Joël Bougáret

Title: Joël Bougáret: Innovator in Medicinal Chemistry

Introduction

Joël Bougáret is a notable inventor based in Francarville, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel pharmaceutical compounds. His work focuses on addressing critical health issues, including dyslipidemia.

Latest Patents

Bougáret holds a patent for "Anilide and cyclodextrin complexes, their preparation and their use as medicine in particular for treating dyslipidemiae." This invention specifically involves dodecylthio-phenylacetanilide derivative complexes, such as (S)-2',3′,5′-trimethyl-4′-hydroxy-α-dodecylthio-phenylacetanilide, and related derivatives combined with cyclodextrins. This innovative approach aims to enhance the efficacy of treatments for dyslipidemia.

Career Highlights

Joël Bougáret is associated with Pierre Fabre Medicament, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to focus on the development of new medicinal compounds that can significantly impact patient care.

Collaborations

Bougáret collaborates with esteemed colleagues, including Elie Leverd and Marie-Dominique Ibarra. These partnerships enhance the research and development process, fostering innovation in the field of medicinal chemistry.

Conclusion

Joël Bougáret's contributions to medicinal chemistry through his patent and collaborations highlight his commitment to advancing healthcare solutions. His work continues to pave the way for innovative treatments that address important medical conditions.